These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2563527)

  • 21. [Basic and clinical studies of brain perfusion scintigraphy using 99mTc-d,l-hexamethyl-propyleneamine oxime].
    Matsuda H; Terada H; Higashi S; Sumiya H; Tsuji S; Seki H; Oba H; Fujii H; Ikeda K; Imai K
    Kaku Igaku; 1987 Sep; 24(9):1329-41. PubMed ID: 3501813
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
    Terada H; Gomi T; Furukawa T; Murakami S; Sato S; Nagamoto M; Sekiguchi R; Kuwajima A; Hiramatsu Y; Sakai T
    Kaku Igaku; 1991 May; 28(5):509-15. PubMed ID: 1886285
    [No Abstract]   [Full Text] [Related]  

  • 23. Serial studies of cerebral blood flow using 99Tcm-HMPAO: a comparison with 133Xe.
    Andersen AR; Friberg H; Lassen NA; Kristensen K; Neirinckx RD
    Nucl Med Commun; 1987 Jul; 8(7):549-57. PubMed ID: 3500434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased 99mTc-HMPAO uptake in ischemic stroke.
    Baird AE; Donnan GA
    Stroke; 1993 Aug; 24(8):1261-2. PubMed ID: 8342204
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined SPECT imaging of regional cerebral blood flow (99mTc-hexamethyl-propyleneamine oxime, HMPAO) and blood volume (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease.
    Buell U; Braun H; Ferbert A; Stirner H; Weiller C; Ringelstein EB
    Nuklearmedizin; 1988 Mar; 27(2):51-6. PubMed ID: 3259313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spurious description of hyperfixation of HMPAO.
    Patterson J; Wyper DJ; Hadley DM
    AJNR Am J Neuroradiol; 1996 May; 17(5):998-9; author reply 999-1000. PubMed ID: 8733979
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
    Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of regional cerebral blood flow in stroke patients using technetium 99m HMPAO.
    Smith FW; Donald RT; Morris AJ; Sharp PF; Gemmell HG
    Br J Radiol; 1988 May; 61(725):358-61. PubMed ID: 3382864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of cerebral infarct and arteriovenous malformation demonstrated by Tc-99m HMPAO and Tc-99m RBC SPECT imaging.
    Gini A; Holmes RA
    Clin Nucl Med; 1989 Apr; 14(4):303-5. PubMed ID: 2785017
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cerebral perfusion SPECT using Tc-99m-d,l-HMPAO: comparative study with I-123 IMP and CBF measured by PET].
    Nishizawa S; Yonekura Y; Fujita T; Senda M; Konishi J; Ishikawa M; Fukuyama H
    Kaku Igaku; 1987 Oct; 24(10):1521-8. PubMed ID: 3502007
    [No Abstract]   [Full Text] [Related]  

  • 31. Cerebral blood flow-to-blood volume imaging by SPECT.
    Buell U; Stirner H; Ferbert F
    J Nucl Med; 1986 Dec; 27(12):1938-9. PubMed ID: 3491197
    [No Abstract]   [Full Text] [Related]  

  • 32. [99mTc-hexamethylpropyleneamine oxime (HMPAO)--its diagnostic potentials for assessing the cerebral blood supply (a review)].
    Krotkov FF; Petunina IV
    Med Radiol (Mosk); 1989 Nov; 34(11):29-35. PubMed ID: 2685504
    [No Abstract]   [Full Text] [Related]  

  • 33. [SPECT findings in the hemiparkinson syndrome using 99mTc-HMPAO].
    Neumann C; Baas H; Hefner R; Hör G
    Nuklearmedizin; 1989 Jun; 28(3):92-4. PubMed ID: 2787025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-HMPAO as a tumour blood flow agent.
    Hammersley PA; McCready VR; Babich JW; Coghlan G
    Eur J Nucl Med; 1987; 13(2):90-4. PubMed ID: 3609059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience with technetium-99m HM-PAO brain SPECT.
    Podreka I; Suess E; Goldenberg G; Steiner M; Brücke T; Müller C; Lang W; Neirinckx RD; Deecke L
    J Nucl Med; 1987 Nov; 28(11):1657-66. PubMed ID: 3499489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake of SPECT radiopharmaceuticals in neocortical brain cultures.
    de Jong BM; van Royen EA
    Eur J Nucl Med; 1989; 15(1):16-20. PubMed ID: 2537215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary results of 99mTc-HMPAO-SPECT studies in endogenous psychoses].
    Wilhelm KR; Schröder J; Henningsen H; Sauer H; Georgi P
    Nuklearmedizin; 1989 Jun; 28(3):88-91. PubMed ID: 2787024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Linealization correction for acetazolamide (Diamox) 99mTc-HMPAO SPECT image--a comparative study with PET].
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1994 Mar; 31(3):277-82. PubMed ID: 8176867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tc-99m-HMPAO brain scintigraphy: a comparative study with I-123-IMP].
    Nishimoto H; Yamamoto Y; Yoshida S; Akagi N; Ohara S; Kamiike O; Maeda T
    Kaku Igaku; 1989 Apr; 26(4):545-50. PubMed ID: 2788761
    [No Abstract]   [Full Text] [Related]  

  • 40. [Unusual accumulation of I-123 IMP and Tc-99m HMPAO in glioblastoma multiforme].
    Maeda H; Kobayashi H; Hayashi M; Ishii Y
    Kaku Igaku; 1988 Jul; 25(7):655-8. PubMed ID: 2846931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.